Printer Friendly

Valens enters into cannabis extraction agreement with Organigram.

M2 PHARMA-January 30, 2019-Valens enters into cannabis extraction agreement with Organigram


Cannabis services company Valens GroWorks Corp (CSE:VGW)(OTC:VGWCF) said on Tuesday that it has signed a agreement for cannabis and hemp extraction services with Organigram Inc (TSXV:OGI)(OTC:OGRMF) with immediate effect.

Under the terms of the multi year agreement, Valens will extract cannabis flowers and trim from Organigram's Moncton operation as well as hemp to produce extract concentrate. The concentrate will be used by Organigram to produce oils and eventually, derivative edible and vaporizable cannabis products.

Pursuant to the agreement, Valens will provide lab services for Organigram as needed.

The legalization of cannabis edibles and other derivative based products in Canada is expected later this year.

((Comments on this story may be sent to

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Jan 30, 2019
Previous Article:Trovagene announces US FDA's may proceed notification for Phase 1b/2 trial of Onvansertib in metastatic colorectal cancer patients.
Next Article:Fresenius Kabi Introduces Leucovorin Calcium Injection, USP.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters